155 results
Page 7 of 8
8-K
l7blnlrgmrz
31 Dec 08
Departure of Directors or Principal Officers
12:00am
8-K
EX-10.3
5ajjir1wf at
31 Dec 08
Departure of Directors or Principal Officers
12:00am
8-K
EX-10.5
qlllh1zi1ltr9c e96
31 Dec 08
Departure of Directors or Principal Officers
12:00am
8-K
j93 rs9gd
12 Jun 08
Departure of Directors or Principal Officers
12:00am
8-K
EX-10.2
ytpaqimc7ko4l
12 Jun 08
Departure of Directors or Principal Officers
12:00am
10-K
3y6o6q83p6fc 40r
8 Feb 08
Annual report
12:00am
8-K
EX-10.9
3cesugy
13 Nov 07
Amicus Therapeutics and Shire plc enter into $440 million ex-US Licensing Agreement to Develop and Commercialize AmigalTM, PliceraTMand AT2220
12:00am
8-K
07928ob68uhr8i4ur
13 Nov 07
Amicus Therapeutics and Shire plc enter into $440 million ex-US Licensing Agreement to Develop and Commercialize AmigalTM, PliceraTMand AT2220
12:00am
8-K
EX-10.5
194zud
13 Nov 07
Amicus Therapeutics and Shire plc enter into $440 million ex-US Licensing Agreement to Develop and Commercialize AmigalTM, PliceraTMand AT2220
12:00am
8-K
EX-10.7
l5pyy50
13 Nov 07
Amicus Therapeutics and Shire plc enter into $440 million ex-US Licensing Agreement to Develop and Commercialize AmigalTM, PliceraTMand AT2220
12:00am
8-K
EX-10.6
xmltai
13 Nov 07
Amicus Therapeutics and Shire plc enter into $440 million ex-US Licensing Agreement to Develop and Commercialize AmigalTM, PliceraTMand AT2220
12:00am
8-K
EX-10.1
4mtwp
13 Nov 07
Amicus Therapeutics and Shire plc enter into $440 million ex-US Licensing Agreement to Develop and Commercialize AmigalTM, PliceraTMand AT2220
12:00am
8-K
EX-10.4
hbd xh2k6xm
13 Nov 07
Amicus Therapeutics and Shire plc enter into $440 million ex-US Licensing Agreement to Develop and Commercialize AmigalTM, PliceraTMand AT2220
12:00am
8-K
EX-10.8
o7e35n2562
13 Nov 07
Amicus Therapeutics and Shire plc enter into $440 million ex-US Licensing Agreement to Develop and Commercialize AmigalTM, PliceraTMand AT2220
12:00am
8-K
EX-10.2
iaquqfaeig 5pt
13 Nov 07
Amicus Therapeutics and Shire plc enter into $440 million ex-US Licensing Agreement to Develop and Commercialize AmigalTM, PliceraTMand AT2220
12:00am
8-K
EX-10.3
zb04ynp
13 Nov 07
Amicus Therapeutics and Shire plc enter into $440 million ex-US Licensing Agreement to Develop and Commercialize AmigalTM, PliceraTMand AT2220
12:00am
424B4
imne 4whtewqrg
31 May 07
Prospectus supplement with pricing info
12:00am